Proenkephalin A-derived peptide E and its fragments alter opioid contractility in the small intestine

Thomas P Davis, Gifford L. Hoyer, Peg Davis, Thomas F. Burks

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The human and canine small intestine exhibit increased contractility when exposed to exogenous or endogenous opioid peptides. The response of the canine small intestine to the proenkephalin A-derived peptide, peptide E and related processing fragments [Met5]enkephalin, BAM-12P, BAM-18P and BAM-22P was investigated by administering each peptide to isolated, small intestine segments which causes a significant increase in intraluminal pressure. Concentration-response curves from intraarterial bolus administration of peptide E, [Met5]enkephalin, BAM-12P, BAM-18P and BAM-22P showed decreasing efficacy with decreasing amino acid chain length while naloxone (305 nM) significantly antagonized the response. Results using the classical guinea pig ileum/myenteric plexus longitudinal muscle and mouse vas deferens bioassays with specific opioid receptor antagonists provide evidence that peptide E and BAM-18P are relatively specific to the μ opioid receptor, [Met5]enkephalin is more δ specific, BAM-22P is both μ and κ specific and BAM-12P is κ opioid receptor specific. These studies demonstrate that locally released (and possibly circulating) peptide E and related processing fragments increase contractility in the small intestine and may be active through more than a single receptor mechanism, particularly the μ receptor.

Original languageEnglish (US)
Pages (from-to)253-261
Number of pages9
JournalEuropean Journal of Pharmacology
Volume191
Issue number3
DOIs
StatePublished - Dec 4 1990

Fingerprint

Opioid Analgesics
Small Intestine
Enkephalins
Opioid Receptors
Canidae
Myenteric Plexus
Peptides
Vas Deferens
Opioid Peptides
Narcotic Antagonists
Naloxone
Ileum
Biological Assay
Guinea Pigs
Amino Acids
Pressure
Muscles
peptide E (adrenal medulla)
proenkephalin
BAM 22P

Keywords

  • BAM-12P
  • BAM-18P
  • BAM-22P
  • Peptide E
  • [Met]enkephalin

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Proenkephalin A-derived peptide E and its fragments alter opioid contractility in the small intestine. / Davis, Thomas P; Hoyer, Gifford L.; Davis, Peg; Burks, Thomas F.

In: European Journal of Pharmacology, Vol. 191, No. 3, 04.12.1990, p. 253-261.

Research output: Contribution to journalArticle

Davis, Thomas P ; Hoyer, Gifford L. ; Davis, Peg ; Burks, Thomas F. / Proenkephalin A-derived peptide E and its fragments alter opioid contractility in the small intestine. In: European Journal of Pharmacology. 1990 ; Vol. 191, No. 3. pp. 253-261.
@article{5b939b28720b43f5a3dda1ad7503ff0c,
title = "Proenkephalin A-derived peptide E and its fragments alter opioid contractility in the small intestine",
abstract = "The human and canine small intestine exhibit increased contractility when exposed to exogenous or endogenous opioid peptides. The response of the canine small intestine to the proenkephalin A-derived peptide, peptide E and related processing fragments [Met5]enkephalin, BAM-12P, BAM-18P and BAM-22P was investigated by administering each peptide to isolated, small intestine segments which causes a significant increase in intraluminal pressure. Concentration-response curves from intraarterial bolus administration of peptide E, [Met5]enkephalin, BAM-12P, BAM-18P and BAM-22P showed decreasing efficacy with decreasing amino acid chain length while naloxone (305 nM) significantly antagonized the response. Results using the classical guinea pig ileum/myenteric plexus longitudinal muscle and mouse vas deferens bioassays with specific opioid receptor antagonists provide evidence that peptide E and BAM-18P are relatively specific to the μ opioid receptor, [Met5]enkephalin is more δ specific, BAM-22P is both μ and κ specific and BAM-12P is κ opioid receptor specific. These studies demonstrate that locally released (and possibly circulating) peptide E and related processing fragments increase contractility in the small intestine and may be active through more than a single receptor mechanism, particularly the μ receptor.",
keywords = "BAM-12P, BAM-18P, BAM-22P, Peptide E, [Met]enkephalin",
author = "Davis, {Thomas P} and Hoyer, {Gifford L.} and Peg Davis and Burks, {Thomas F.}",
year = "1990",
month = "12",
day = "4",
doi = "10.1016/0014-2999(90)94157-S",
language = "English (US)",
volume = "191",
pages = "253--261",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Proenkephalin A-derived peptide E and its fragments alter opioid contractility in the small intestine

AU - Davis, Thomas P

AU - Hoyer, Gifford L.

AU - Davis, Peg

AU - Burks, Thomas F.

PY - 1990/12/4

Y1 - 1990/12/4

N2 - The human and canine small intestine exhibit increased contractility when exposed to exogenous or endogenous opioid peptides. The response of the canine small intestine to the proenkephalin A-derived peptide, peptide E and related processing fragments [Met5]enkephalin, BAM-12P, BAM-18P and BAM-22P was investigated by administering each peptide to isolated, small intestine segments which causes a significant increase in intraluminal pressure. Concentration-response curves from intraarterial bolus administration of peptide E, [Met5]enkephalin, BAM-12P, BAM-18P and BAM-22P showed decreasing efficacy with decreasing amino acid chain length while naloxone (305 nM) significantly antagonized the response. Results using the classical guinea pig ileum/myenteric plexus longitudinal muscle and mouse vas deferens bioassays with specific opioid receptor antagonists provide evidence that peptide E and BAM-18P are relatively specific to the μ opioid receptor, [Met5]enkephalin is more δ specific, BAM-22P is both μ and κ specific and BAM-12P is κ opioid receptor specific. These studies demonstrate that locally released (and possibly circulating) peptide E and related processing fragments increase contractility in the small intestine and may be active through more than a single receptor mechanism, particularly the μ receptor.

AB - The human and canine small intestine exhibit increased contractility when exposed to exogenous or endogenous opioid peptides. The response of the canine small intestine to the proenkephalin A-derived peptide, peptide E and related processing fragments [Met5]enkephalin, BAM-12P, BAM-18P and BAM-22P was investigated by administering each peptide to isolated, small intestine segments which causes a significant increase in intraluminal pressure. Concentration-response curves from intraarterial bolus administration of peptide E, [Met5]enkephalin, BAM-12P, BAM-18P and BAM-22P showed decreasing efficacy with decreasing amino acid chain length while naloxone (305 nM) significantly antagonized the response. Results using the classical guinea pig ileum/myenteric plexus longitudinal muscle and mouse vas deferens bioassays with specific opioid receptor antagonists provide evidence that peptide E and BAM-18P are relatively specific to the μ opioid receptor, [Met5]enkephalin is more δ specific, BAM-22P is both μ and κ specific and BAM-12P is κ opioid receptor specific. These studies demonstrate that locally released (and possibly circulating) peptide E and related processing fragments increase contractility in the small intestine and may be active through more than a single receptor mechanism, particularly the μ receptor.

KW - BAM-12P

KW - BAM-18P

KW - BAM-22P

KW - Peptide E

KW - [Met]enkephalin

UR - http://www.scopus.com/inward/record.url?scp=0025675484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025675484&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(90)94157-S

DO - 10.1016/0014-2999(90)94157-S

M3 - Article

C2 - 2086244

AN - SCOPUS:0025675484

VL - 191

SP - 253

EP - 261

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -